PubMed Health⌕ Search

SEARCH · PubMed Health

Results for “ETHICS, PHARMACEUTICAL”

Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 127 records · Page 7Linked to original sources
PubMedDate not supplied

Marketing and commercial challenges for anticancer products.

Traditional marketing techniques that are employed by pharmaceutical manufacturers are not adequate in the oncology setting. Many unique characteristics of this therapeutic area create challenges to the marketing and sales teams responsible for selling anticancer and cancer-therapy support products. There is a high burden on those marketing oncology products to provide vast amounts of information about their products, in a timely manner, to various groups of health care providers, while functioning within established legal boundaries. Pharmaceutical companies, through their sales and marketing efforts, are working to provide the information health care providers need to make patient management decisions and prevent the health care environment from restricting physician and patient choices.

Antineoplastic Agents↗
PubMedDate not supplied

Psychiatric training program engagement with the pharmaceutical industry: an educational issue, not strictly an ethical one.

OBJECTIVE: To analyze the educational and ethical issues involved in interactions between departments of psychiatry and the pharmaceutical industry. METHODS: The author analyzes the history of attitudes toward pharmaceutical companies, various conflicting ethical principles that apply, and areas of confluence and conflict of interest between psychiatric education and the drug industry. These attitudes are applied to a variety of specific types of interactions with representatives of the pharmaceutical industry. RESULTS: A number of forms of interaction are found to be on balance, ethical, and productive, while others are found to be problematic. CONCLUSIONS: Careful analysis of both ethical and educational dimensions can produce meaningful and constructive involvement with the pharmaceutical industry, without inevitably corrupting psychiatric educators.

Drug Industry↗
PubMed2002

Transnational pharmaceutical corporations and neo-liberal business ethics in India.

The author critiques the expedient application of market valuation principles by the transnational corporations and other large firms in the Indian pharmaceutical industry on a number of issues like patents, pricing, irrational drugs, clinical trials, etc. He contends that ethics in business is chiseled and etched within the confines of particular social structures of accumulation. An ascendant neo-liberal social structure of accumulation has basically shaped these firms' sharp opposition to the Indian Patents Act, 1970, government administered pricing, etc. The author contents that the practice of neo-liberal economics is strongly associated with a "one-dimensional" ethics that privileges market valuation principles over all others. This seems to inevitably generate a social counter-movement that struggles for social protections. He critiques neo-liberal business practices from a perspective that derives from the work of the economic anthropologist Karl Polanyi. Before the present phase of liberalization in India, markets were "managed", but without a "welfare state" in place. Moving toward deregulation of the markets without a welfare state in place is unethical. Keeping the debilities of the institutional framework of public policy in mind, the author adopts a Polanyian perspective that places its trust and hope in the growing social legitimacy of the counter-movement in opposition to both neo-liberal business practices and the degenerate behavior of state agencies.

Advertising↗